{"id":9028,"date":"2026-07-01T17:45:00","date_gmt":"2026-07-01T15:45:00","guid":{"rendered":"https:\/\/intrasense.fr\/?post_type=actualite&#038;p=9028"},"modified":"2026-07-02T10:11:23","modified_gmt":"2026-07-02T08:11:23","slug":"proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology","status":"publish","type":"actualite","link":"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/","title":{"rendered":"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Intrasense, a French specialist in AI-enhanced medical imaging solutions supporting diagnosis, clinical decision-making and therapeutic monitoring (\"Intrasense\" or the \"Company\"), announces that it has received a firm and irrevocable offer from EDL for the acquisition of its Myrian\u00ae business.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Intrasense, a French specialist in AI-enhanced medical imaging solutions supporting diagnosis, clinical decision-making and therapeutic monitoring (\"Intrasense\" or the \"Company\"), announces that it has received a firm and irrevocable offer from EDL for the acquisition of its Myrian\u00ae business.<\/p>\n","protected":false},"author":2,"featured_media":0,"template":"","categories":[83],"class_list":["post-9028","actualite","type-actualite","status-publish","hentry","category-press-releases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan - Intrasense<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan - Intrasense\" \/>\n<meta property=\"og:description\" content=\"Intrasense, a French specialist in AI-enhanced medical imaging solutions supporting diagnosis, clinical decision-making and therapeutic monitoring (&quot;Intrasense&quot; or the &quot;Company&quot;), announces that it has received a firm and irrevocable offer from EDL for the acquisition of its Myrian\u00ae business.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Intrasense\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-02T08:11:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/intrasense.fr\\\/en\\\/actualite\\\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\\\/\",\"url\":\"https:\\\/\\\/intrasense.fr\\\/en\\\/actualite\\\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\\\/\",\"name\":\"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan - Intrasense\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/intrasense.fr\\\/fr\\\/#website\"},\"datePublished\":\"2026-07-01T15:45:00+00:00\",\"dateModified\":\"2026-07-02T08:11:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/intrasense.fr\\\/en\\\/actualite\\\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/intrasense.fr\\\/en\\\/actualite\\\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/intrasense.fr\\\/en\\\/actualite\\\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/intrasense.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/intrasense.fr\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/intrasense.fr\\\/fr\\\/\",\"name\":\"Intrasense\",\"description\":\"A website using WP\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/intrasense.fr\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan - Intrasense","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/","og_locale":"en_US","og_type":"article","og_title":"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan - Intrasense","og_description":"Intrasense, a French specialist in AI-enhanced medical imaging solutions supporting diagnosis, clinical decision-making and therapeutic monitoring (\"Intrasense\" or the \"Company\"), announces that it has received a firm and irrevocable offer from EDL for the acquisition of its Myrian\u00ae business.","og_url":"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/","og_site_name":"Intrasense","article_modified_time":"2026-07-02T08:11:23+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/","url":"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/","name":"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan - Intrasense","isPartOf":{"@id":"https:\/\/intrasense.fr\/fr\/#website"},"datePublished":"2026-07-01T15:45:00+00:00","dateModified":"2026-07-02T08:11:23+00:00","breadcrumb":{"@id":"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/intrasense.fr\/en\/actualite\/proposed-disposal-of-intrasenses-myrian-business-to-edl-and-acceleration-of-intrasenses-transformation-into-a-pure-player-artificial-intelligence-company-dedicated-to-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/intrasense.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Proposed Disposal of Intrasense\u2019s Myrian\u00ae Business to EDL and Acceleration of Intrasense\u2019s Transformation into a Pure-Player Artificial Intelligence Company Dedicated to Oncology. A transformative transaction that would enable Intrasense to focus its resources on the development of its DUOnco\u2122 platform and the implementation of its IN2ONCO strategic plan"}]},{"@type":"WebSite","@id":"https:\/\/intrasense.fr\/fr\/#website","url":"https:\/\/intrasense.fr\/fr\/","name":"Intrasense","description":"A website using WP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/intrasense.fr\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/intrasense.fr\/en\/wp-json\/wp\/v2\/actualite\/9028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/intrasense.fr\/en\/wp-json\/wp\/v2\/actualite"}],"about":[{"href":"https:\/\/intrasense.fr\/en\/wp-json\/wp\/v2\/types\/actualite"}],"author":[{"embeddable":true,"href":"https:\/\/intrasense.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"wp:attachment":[{"href":"https:\/\/intrasense.fr\/en\/wp-json\/wp\/v2\/media?parent=9028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/intrasense.fr\/en\/wp-json\/wp\/v2\/categories?post=9028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}